Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. lung transplant
Show results for
Products
Services

Companies

News
Articles

Refine by
Date

  • Older

Lung Transplant Articles & Analysis

11 news found

New Potential In Lung Fibrosis Treatment With Lung Cell Transplantation

New Potential In Lung Fibrosis Treatment With Lung Cell Transplantation

However, a recent study by Milman-Krentsis (2024) offers a beacon of hope, demonstrating the potential of lung cell transplantation as a therapeutic intervention for lung fibrosis. Utilizing two distinct mouse models—one treated with bleomycin and another genetically modified to lack telomeric repeat-binding factor 1 (TRF1) in alveolar type ...

BySCIREQ - an emka TECHNOLOGIES Company


Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Until now, the only other options for these patients were invasive treatments such as lung volume reduction surgery or lung transplantation. The one-way Zephyr Valves are placed in a selected lobe of the lung (generally the most diseased lobe and with little to no collateral ventilation) during a bronchoscopic procedure to ...

ByPulmonx Corporation


AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a Multi-Virus-Specific T Cell Therapy, for the Treatment of BK Viremia in Kidney Transplant Recipients

AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a Multi-Virus-Specific T Cell Therapy, for the Treatment of BK Viremia in Kidney Transplant Recipients

These data were shared today in an oral plenary presentation at the American Transplant Congress (ATC) in Boston (Abstract 387). “Kidney transplant recipients are particularly challenged by BK viremia, which puts the survival of their transplanted graft at risk,” said Anil K. ...

ByKalaris


New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device

New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device

These data were presented at the International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions – which brought together the world’s leading experts in heart and lung transplant, held from April 27-30th, in Boston, MA. ...

ByDaxor Corporation


BenevolentAI Achieves Second Major Collaboration Milestone With Novel Idiopathic Pulmonary Fibrosis Target Selected For AstraZeneca’s Portfolio

BenevolentAI Achieves Second Major Collaboration Milestone With Novel Idiopathic Pulmonary Fibrosis Target Selected For AstraZeneca’s Portfolio

IPF is a chronic and ultimately fatal disease that causes lung tissue to stiffen, leading to permanent lung scarring that makes it harder to breathe. As IPF progresses, patients often need oxygen and, in some cases, lung transplantation. With a median survival of ∼3 years, the prognosis can be devastating, and there is a ...

ByBenevolent


Versius surgical robot used for first time in an Italian public hospital

Versius surgical robot used for first time in an Italian public hospital

” At Policlinico di Milano, Versius will be used to perform a range of procedures including cholecystectomy, lower anterior resection and pulmonary resection surgery, a procedure used to treat lung cancer. Using robotic keyhole surgery in these cases can significantly reduce the physical strain of surgery for the surgeon. In comparison to open surgery, keyhole surgery has ...

ByCMR Surgical Ltd


The Ultimate List of Attractive MedTech M&A Targets

The Ultimate List of Attractive MedTech M&A Targets

The company’s first product, the SherpaPak Cardiac Transport System (CTS), is designed to protect heart transplants from physical and thermal trauma in a dual-canister compartment. Paragonix also has a system for donor lung preservation, and a SherpaPak Pancreas Transport System. In late April, the First Report of the GUARDIAN Registry was presented at the ...

ByAnuncia Medical, Inc.


CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT). The company presented the first ever study demonstrating sensorless synchronization of a ...

ByCorWave


Carmat outlines commercial and development plan for its total artificial heart

Carmat outlines commercial and development plan for its total artificial heart

Commercial opportunity and plan Significant market opportunity The CE marking for the CARMAT heart as a bridge-to-transplant (BTT) represents a very significant market opportunity with a minimum of 2,000 patients currently on waiting lists for a heart transplant in five major European countries[5]. ...

ByCarmat


AdjuCor’s first international conference presentation has been confirmed – 41st ISHLT Annual Meeting & Scientific Sessions

AdjuCor’s first international conference presentation has been confirmed – 41st ISHLT Annual Meeting & Scientific Sessions

For the very first time, AdjuCor GmbH's revolutionary new heart-assist technology – BEAT – will take the stage at the prestigious 41st International Society for Heart and Lung Transplantation (#ISHLT2021). Prof. Ulrich Stock will be presenting BEAT’s acute and chronic preclinical results, proudly showcasing this first-in-class technology and how ...

ByAdjuCor GmbH


CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting

CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting

Professor André Vincentelli, MD, Head of the Mechanical Circulatory Support and Transplantation Program at Lille University Hospital and a scientific partner of CorWave, commented, “CorWave continues its remarkable progress and reaches a major milestone towards clinical application with these 6-month real-time ...

ByCorWave

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT